Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zacks Small Cap Research is an independent equity research firm that provides institutional-quality analysis on small-cap and micro-cap companies, with a significant focus on the healthcare and biotechnology sectors. The firm specializes in covering under-followed public companies, offering detailed financial modeling, valuation analysis, and strategic commentary to help investors navigate the complexities of emerging life science entities. Their team of analysts, many of whom hold advanced scientific or financial degrees, produce comprehensive reports on clinical-stage biotech, medical device, and diagnostic companies. By providing transparent and accessible research, Zacks SCR aims to improve market visibility and liquidity for smaller issuers while offering actionable insights for institutional and retail investors. The division is well-known for its sponsored research model, which allows smaller companies to obtain professional analyst coverage that might otherwise be unavailable from larger Wall Street banks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zacks Small Cap Research.